2834 – Page 96 – China Stock Advice

TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)

[Tianyin Pharmaceutical Management Hosts Annual General Meeting May 8, 2013 10:00 AM ET . Operator James Jiayuan Tong - As the by-laws provide, I will act as Chairperson of the meeting. Our Corporate Secretary, Mr. Lou Taubman, will act as Secretary of the meeting. I would like to take this opportunity to introduce the directors and officers of the Company] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT May 8, 2013 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]

By info| 2016-03-27T18:26:50+00:00 May 13th, 2013|Categories: Chinese Stocks, SEC Original, TPI|Tags: 0001362718, 2013-05-13, 2834, 8-K, PHARMACEUTICAL PREPARATIONS, TPI|0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: Tianyin Pharmaceutical Management Hosts Annual General Meeting May

[Tianyin Pharmaceutical Management Hosts Annual General Meeting May 8, 2013 10:00 AM ET . Operator James Jiayuan Tong - As the by-laws provide, I will act as Chairperson of the meeting. Our Corporate Secretary, Mr. Lou Taubman, will act as Secretary of the meeting. I would like to take this opportunity to introduce the directors and officers of the Company] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT May 8, 2013 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]

By info| 2016-03-27T18:28:31+00:00 May 13th, 2013|Categories: Chinese Stocks, TPI, Webplus ver|Tags: 0001362718, 2013-05-13, 2834, 8-K, PHARMACEUTICAL PREPARATIONS, TPI|0 Comments

SVA [SINOVAC BIOTECH] SC 13G: (Original Filing)

[SCHEDULE 13G (Amendment No. SINOVAC BIOTECH LTD. (Name of Issuer) (Title of Class of Securities) (CUSIP Number) (Date of Event Which Requires Filing of This Statement) o Rule 13d-1(b) x Rule 13d-1(c) o Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class]

By info| 2016-03-24T00:39:17+00:00 May 9th, 2013|Categories: Chinese Stocks, SEC Original, SVA|Tags: 0001084201, 2013-05-09, 2834, PHARMACEUTICAL PREPARATIONS, SC_13G, SVA|0 Comments

SVA [SINOVAC BIOTECH] SC 13G: SCHEDULE 13G (Amendment No. SINOVAC BIOTECH LTD. (Name

[SCHEDULE 13G (Amendment No. SINOVAC BIOTECH LTD. (Name of Issuer) (Title of Class of Securities) (CUSIP Number) (Date of Event Which Requires Filing of This Statement) o Rule 13d-1(b) x Rule 13d-1(c) o Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class]

By info| 2016-03-24T00:40:23+00:00 May 9th, 2013|Categories: Chinese Stocks, SVA, Webplus ver|Tags: 0001084201, 2013-05-09, 2834, PHARMACEUTICAL PREPARATIONS, SC_13G, SVA|0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)

[FORM 8-K CURRENT REPORT FOR ISSUERS SUBJECT TO THE CURRENT REPORT May 8, 2013 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co., Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]

By info| 2016-03-27T18:29:59+00:00 May 9th, 2013|Categories: Chinese Stocks, SEC Original, TPI|Tags: 0001362718, 2013-05-09, 2834, 8-K, PHARMACEUTICAL PREPARATIONS, TPI|0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[______________ FORM 8-K ______________ CURRENT REPORT Date of Report (Date of earliest event reported): May 1, 2013 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ¨]

By info| 2016-03-03T11:08:55+00:00 May 6th, 2013|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 2013-05-06, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: FORM 8-K CURRENT REPORT Date of

[______________ FORM 8-K ______________ CURRENT REPORT Date of Report (Date of earliest event reported): May 1, 2013 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ¨]

By info| 2016-03-03T11:10:18+00:00 May 6th, 2013|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 2013-05-06, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[______________ FORM 8-K ______________ CURRENT REPORTte of Report (Date of earliest event reported):May 1, 2013 BIOSTAR PHARMACEUTICALS, Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer oforporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province Peoples Republic of China 712046 86-029-33686638 N/A (Former name or formerdress, if changed since last report)]

By info| 2016-02-07T15:20:29+00:00 May 6th, 2013|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 2013-05-06, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: FORM 8-K CURRENT REPORTte of Report

[______________ FORM 8-K ______________ CURRENT REPORTte of Report (Date of earliest event reported):May 1, 2013 BIOSTAR PHARMACEUTICALS, Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer oforporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province Peoples Republic of China 712046 86-029-33686638 N/A (Former name or formerdress, if changed since last report)]

By info| 2016-02-07T15:21:23+00:00 May 6th, 2013|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 2013-05-06, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Reports Preliminary Top-Line Results from Phase III Clinical Trial for EV71 Vaccine Candidate Against Hand, Foot and Mouth Disease -- Unblinded Phase III Preliminary Results Demonstrate Vaccine Efficacy Rate of 95.4% SVA BEIJING, March 14, 2013 /PRNewswire/ -- Sinovac Biotech Ltd. ( ir@sinovac.com scarrington@theruthgroup.com aestrada@theruthgroup.com] [Sinovac Schedules Conference Call and Webcast for Fourth Quarter and Full Year Unaudited Financial Results Beijing – April 2, 2013 – Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of vaccines in China, today announced that it will release its unaudited financial results for the fourth quarter and full year ended December 31, 2012, before market on Thursday, April 18,] [Sinovac Receives Commercial Approval in Mexico for Seasonal Flu Vaccine SVA Beijing – April 18, 2013 – Sinovac Biotech Ltd. (Nasdaq: Dr. Weidong Yin, Chairman, President and CEO of Sinovac, said, “ This is a great milestone for Sinovac as we look to continue expanding our commercial efforts worldwide. We are pleased to receive approval to supply Anflu in the] [Sinovac EV71 Vaccine Phase III Top-Line Results Presented at 13th Annual World Vaccine Congress & Expo – Efficacy and Safety Data for EV71 Vaccine Discussed in Presentation by Deputy Director of Jiangsu Provincial CDC Beijing – April 18, 2013 – Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of vaccines in China,announced today that Fengcai Zhu, Deputy Director of the] [Sinovac Reports Unaudited Fourth Quarter and Full Year 2012 Financial Results – Conference call scheduled for Thursday, April 18, 2013 at 8:00 AM EDT– – Sinovac Biotech Ltd. ( today its unaudited fourth quarter and full year Beijing – April 18, 2013 Financial Highlights l Total sales were $19.0 million for the fourth quarter of 2012, a decrease of 10.4%] []

By info| 2016-03-24T00:41:44+00:00 May 3rd, 2013|Categories: Chinese Stocks, SEC Original, SVA|Tags: 0001084201, 2013-05-03, 2834, 6-K, PHARMACEUTICAL PREPARATIONS, SVA|0 Comments